The COVID-19 pandemic has forced countless difficult decisions to be made in the face of unprecedented uncertainty. Patients, consumers, and industry professionals alike are looking for guidance, support, and answers. With an increased demand on pharmaceutical manufacturers to develop a COVID-19 therapeutic alongside all the existing treatments that are still needed by millions, there follows the growing need for strict quality control processes, and the ability to test and release large volumes of newly manufactured vaccines. In this webinar, we will explore why now is the right time to renew microbiological quality control and how we will be able to get to a next “normal”.
The rest of longer description is here.